Repligen Corp number of employees

Repligen Corp reported 2,000 employees at December 31, 2025 in its latest annual report, up 222 (12.5%) on the year before. That compares with 1,852 at December 31, 2021. Revenue per employee was $369,128.

Headcount by year

Fiscal year end	Employees	Change	Revenue per employee	Source
December 31, 2025	2,000	+222 (12.5%)	$369,128	10-K, filed February 26, 2026
December 31, 2024	1,778	−5 (0.3%)	$356,827	10-K, filed March 14, 2025
December 31, 2023	1,783	−242 (12.0%)	$354,662	10-K, filed February 22, 2024
December 31, 2022	2,025	+173 (9.3%)	$395,820	10-K, filed February 22, 2023
December 31, 2021	1,852	—	$362,059	10-K, filed February 17, 2022

What the annual reports say

As of December 31, 2025, we employed approximately 2,000 full-time and part-time employees. 2025 annual report
As of December 31, 2024, we employed 1,778 full-time and part-time employees, a decrease of 5 since December 31, 2023. 2024 annual report
As of December 31, 2023, we employed 1,783 full-time and part-time employees, a decrease of 242 since December 31, 2022. 2023 annual report
As of December 31, 2022, we employed 2,025 full-time and part-time employees, an increase of 173 since December 31, 2021. 2022 annual report
As of December 31, 2021, we employed 1,852 full-time and part-time employees, an increase of 724 since December 31, 2020. 2021 annual report

Headcount as the company states it in Item 1 of its annual report (some count full-time equivalents or exclude part-time and temporary staff), at the date it gives. Years where the report states no clear total are left out rather than estimated. Changes can reflect acquisitions and disposals as well as hiring and job cuts.

Compare with peers

Head to head: NEO vs RGEN AZTA vs RGEN RGEN vs TECH

More: Life Sciences Tools & Services stocks compared, Health Care sector, rankings of US companies

Figures from Repligen Corp's SEC filings (10-K and 10-Q), retrieved October 30, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Repligen Corp.